Standout Papers
Citation Impact
Citing Papers
Improving Selection Criteria for Early Cystectomy in High-Grade T1 Bladder Cancer: A Meta-Analysis of 15,215 Patients
2015
In Vivo Activation of the p53 Pathway by Small-Molecule Antagonists of MDM2
2004 StandoutScience
Trained immunity: A program of innate immune memory in health and disease
2016 StandoutScience
Long-Term Outcomes in Patients With Muscle-Invasive Bladder Cancer After Selective Bladder-Preserving Combined-Modality Therapy: A Pooled Analysis of Radiation Therapy Oncology Group Protocols 8802, 8903, 9506, 9706, 9906, and 0233
2014
Efficacy of everolimus in advanced renal cell carcinoma: a double-blind, randomised, placebo-controlled phase III trial
2008 Standout
Bevacizumab plus interferon alfa-2a for treatment of metastatic renal cell carcinoma: a randomised, double-blind phase III trial
2007 Standout
Lymph node density as a prognostic variable in node-positive bladder cancer: a meta-analysis
2015
Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries
2021 Standout
Lymph Node Dissection Technique Is More Important Than Lymph Node Count in Identifying Nodal Metastases in Radical Cystectomy Patients: A Comparative Mapping Study
2011
Concurrent Cisplatin-Based Radiotherapy and Chemotherapy for Locally Advanced Cervical Cancer
1999 Standout
After Cystectomy, Is It Justified to Perform a Bladder Replacement for Patients with Lymph Node Positive Bladder Cancer?
2002
Do Prognostic Parameters of Remission versus Relapse after Bacillus Calmette–Guérin (BCG) Immunotherapy Exist? Analysis of a Quarter Century of Literature
2003
Optimal Management of the T1G3 Bladder Cancer
2005
Quality of Life and Satisfaction with Outcome among Prostate-Cancer Survivors
2008 Standout
Testicular Germ-Cell Cancer
1997 Standout
European Association of Urology Guidelines on Upper Urinary Tract Urothelial Cell Carcinoma: 2015 Update
2015 Standout
Urethral recurrence after radical cystectomy for urothelial carcinoma: A systematic review and meta-analysis
2017
Kidney stones: pathophysiology and medical management
2006 Standout
Curative Therapy for Bladder Cancer in Routine Clinical Practice: A Population-based Outcomes Study
2014
Stromal fibroblasts in cancer initiation and progression
2004 StandoutNature
The β-Chemokine Receptors CCR3 and CCR5 Facilitate Infection by Primary HIV-1 Isolates
1996 Standout
Guidelines on Urolithiasis<footref rid="foot01"><sup>1</sup></footref>
2001 Standout
High-grade urothelial carcinoma of the renal pelvis: clinicopathologic study of 108 cases with emphasis on unusual morphologic variants
2006
Prevention and Management of Complications Following Radical Cystectomy for Bladder Cancer
2010
Incidence, survival and mortality rates of stage-specific bladder cancer in United States: A trend analysis
2013
Cancer‐specific survival after radical cystectomy and standardized extended lymphadenectomy for node‐positive bladder cancer: prediction by lymph node positivity and density
2009
Chemokines and leukocyte traffic
1998 StandoutNature
External Validation of Postoperative Nomograms for Prediction of All-Cause Mortality, Cancer-Specific Mortality, and Recurrence in Patients With Urothelial Carcinoma of the Bladder
2011
T1G3 Bladder Tumours: The Case for Radical Cystectomy
2003
Prospective Health-related Quality of Life Analysis for Patients Undergoing Radical Cystectomy and Urinary Diversion
2014
Clinical Outcome in a Contemporary Series of Restaged Patients with Clinical T1 Bladder Cancer
2009
Increased Survival with Enzalutamide in Prostate Cancer after Chemotherapy
2012 Standout
Consensus statement on best practice management regarding the use of intravesical immunotherapy with BCG for bladder cancer
2015
Adjuvant chemotherapy for high-risk clinical stage I nonseminomatous testicular germ cell cancer: long-term results of a prospective trial.
1996
Chemokines — Chemotactic Cytokines That Mediate Inflammation
1998 Standout
The neural control of micturition
2008 Standout
Evaluation of current surveillance guidelines following radical cystectomy and proposal of a novel risk-based approach
2015
Long-term Cancer-specific Survival in Patients with High-risk, Non–muscle-invasive Bladder Cancer and Tumour Progression: A Systematic Review
2011
Metabolic and functional consequences of urinary reconstruction with bowel
2003
Diagnostic accuracy of multi-parametric MRI and TRUS biopsy in prostate cancer (PROMIS): a paired validating confirmatory study
2017 Standout
Long-term Outcomes After Bladder-preserving Tri-modality Therapy for Patients with Muscle-invasive Bladder Cancer: An Updated Analysis of the Massachusetts General Hospital Experience
2017
The ileal neobladder in female patients with bladder cancer: long-term clinical, functional, and oncological outcome
2012
Guidelines on Bladder Cancer
2002
The Z‐shaped ileal neobladder after radical cystectomy: an 18 years experience with 329 patients
2011
Renal-Cell Carcinoma
1996 Standout
Laparoscopic versus Open Radical Cystectomy in Bladder Cancer: A Systematic Review and Meta-Analysis of Comparative Studies
2014
European Guidelines on Upper Tract Urothelial Carcinomas: 2013 Update
2013
The lymphocyte chemoattractant SDF-1 is a ligand for LESTR/fusin and blocks HIV-1 entry
1996 StandoutNature
Comparison of Complications in Three Incontinent Urinary Diversions
2008
Regression of Metastatic Renal-Cell Carcinoma after Nonmyeloablative Allogeneic Peripheral-Blood Stem-Cell Transplantation
2000 Standout
Small cell carcinoma of the upper urinary tract (UUT-SCC): Report of a rare entity and systematic review of the literature
2011
Long-Term Outcomes of Selective Bladder Preservation by Combined-Modality Therapy for Invasive Bladder Cancer: The MGH Experience
2011
Comparing Open Radical Cystectomy and Robot-assisted Laparoscopic Radical Cystectomy: A Randomized Clinical Trial
2014
Sunitinib versus Interferon Alfa in Metastatic Renal-Cell Carcinoma
2007 Standout
Impact of the Use of Bowel for Urinary Diversion on Perioperative Complications and 90-Day Mortality in Patients Aged 75 Years or Older
2015
Radical cystectomy for invasive bladder cancer: long-term results of a standard procedure
2006
T1G3 Bladder Tumours: The Case for Conservative Treatment
2003
The development of androgen-independent prostate cancer
2001 Standout
Follow-up of patients after curative bladder cancer treatment: guidelines vs. practice
2010
Derivation and validation of a clinical prediction rule for uncomplicated ureteral stone--the STONE score: retrospective and prospective observational cohort studies
2014
ICUD-EAU International Consultation on Bladder Cancer 2012: Radical Cystectomy and Bladder Preservation for Muscle-Invasive Urothelial Carcinoma of the Bladder
2012
Predictive factors of recurrence and survival of upper tract urothelial carcinomas
2011
Renal sympathetic nerve activity modulates afferent renal nerve activity by PGE2-dependent activation of α1- and α2-adrenoceptors on renal sensory nerve fibers
2007
Systematic Review and Individual Patient Data Meta-analysis of Randomized Trials Comparing a Single Immediate Instillation of Chemotherapy After Transurethral Resection with Transurethral Resection Alone in Patients with Stage pTa–pT1 Urothelial Carcinoma of the Bladder: Which Patients Benefit from the Instillation?
2015
EAU-ESTRO-SIOG Guidelines on Prostate Cancer. Part II: Treatment of Relapsing, Metastatic, and Castration-Resistant Prostate Cancer
2016
Blinded by the Light: The Growing Complexity of p53
2009 Standout
Bladder Preservation Strategies
2014
European Association of Urology Guidelines on Muscle-invasive and Metastatic Bladder Cancer: Summary of the 2020 Guidelines
2020 Standout
The dark side of a tumor suppressor: anti-apoptotic p53
2008
Survival Following Primary Androgen Deprivation Therapy Among Men With Localized Prostate Cancer
2008
Predicting Recurrence and Progression in Individual Patients with Stage Ta T1 Bladder Cancer Using EORTC Risk Tables: A Combined Analysis of 2596 Patients from Seven EORTC Trials
2006 Standout
Bladder Cancer Patterns of Pelvic Failure: Implications for Adjuvant Radiation Therapy
2013
Systematic Review on the Fate of the Remnant Urothelium after Radical Cystectomy
2016
Oncologic Outcomes of Kidney-sparing Surgery Versus Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma: A Systematic Review by the EAU Non-muscle Invasive Bladder Cancer Guidelines Panel
2016
EAU Guidelines on Muscle-invasive and Metastatic Bladder Cancer: Summary of the 2013 Guidelines
2013
The Impact of the Extent of Lymphadenectomy on Oncologic Outcomes in Patients Undergoing Radical Cystectomy for Bladder Cancer: A Systematic Review
2014
Critical Analysis of Bladder Sparing with Trimodal Therapy in Muscle-invasive Bladder Cancer: A Systematic Review
2014
Bladder cancer
2016 Standout
Updated 2016 EAU Guidelines on Muscle-invasive and Metastatic Bladder Cancer
2016 Standout
Continent cutaneous urinary diversion: long-term follow-up of more than 800 patients with ileocecal reservoirs
2006
Improved local control of invasive bladder cancer by concurrent cisplatin and preoperative or definitive radiation. The National Cancer Institute of Canada Clinical Trials Group.
1996
Seguimiento oncológico después de cistectomía radical basado en patrones de recidiva tumoral y sus factores de riesgo
2013
Bacillus Calmette‐Guérin therapy in stage Ta/T1 bladder cancer: prognostic factors for time to recurrence and progression
2004
Cardiovascular Mortality and Duration of Androgen Deprivation for Locally Advanced Prostate Cancer: Analysis of RTOG 92-02
2008
Radical Cystectomy for Urothelial Carcinoma of the Bladder Without Neoadjuvant or Adjuvant Therapy: Long-Term Results in 1100 Patients
2012
Sorafenib in Advanced Clear-Cell Renal-Cell Carcinoma
2007 Standout
A rabbit model to tissue engineer the bladder
2003
Prostate cancer and the androgen receptor: Strategies for the development of novel therapeutics
2000
EAU Guidelines on Prostate Cancer. Part 1: Screening, Diagnosis, and Treatment of Clinically Localised Disease
2010
Neoadjuvant Chemotherapy plus Cystectomy Compared with Cystectomy Alone for Locally Advanced Bladder Cancer
2003 Standout
Adjuvant Chemotherapy for Invasive Bladder Cancer: A 2013 Updated Systematic Review and Meta-Analysis of Randomized Trials
2013
Cancer immunotherapy comes of age
2011 StandoutNature
Upper Urinary Tract Transitional Cell Carcinoma: Recurrence Rate after Percutaneous Endoscopic Resection
2006
Extent of lymph node dissection and recurrence-free survival after radical cystectomy: A meta-analysis
2014
A systematic review and meta-analysis of quality of life outcomes after radical cystectomy for bladder cancer
2016
The prognostic role of lymphovascular invasion in urothelial carcinoma of the bladder
2016
Sipuleucel-T Immunotherapy for Castration-Resistant Prostate Cancer
2010 Standout
Anatomic Basis for Lymph Node Counts as Measure of Lymph Node Dissection Extent: A Cadaveric Study
2013
Immediate versus deferred androgen deprivation treatment in patients with node-positive prostate cancer after radical prostatectomy and pelvic lymphadenectomy
2006
Adjuvant and neoadjuvant chemotherapy for invasive bladder cancer
2000
The Role of Surgery in Metastatic Bladder Cancer: A Systematic Review
2017
PI-RADS Prostate Imaging – Reporting and Data System: 2015, Version 2
2015 Standout
Chemohormonal Therapy in Metastatic Hormone-Sensitive Prostate Cancer
2015 Standout
Transurethral surgery and twice-daily radiation plus paclitaxel-cisplatin or fluorouracil-cisplatin with selective bladder preservation and adjuvant chemotherapy for patients with muscle invasive bladder cancer (RTOG 0233): a randomised multicentre phase 2 trial
2013
Best Practices in Robot-assisted Radical Cystectomy and Urinary Reconstruction: Recommendations of the Pasadena Consensus Panel
2015
Urinary Diversions after Cystectomy: The Association of Clinical Factors, Complications and Functional Results of Four Different Diversions
2007
Tolvaptan in Patients with Autosomal Dominant Polycystic Kidney Disease
2012 Standout
Lymphadenectomy at the Time of Nephroureterectomy for Upper Tract Urothelial Cancer
2011
American Cancer Society Guideline for the Early Detection of Prostate Cancer: Update 2010
2010
Urinary functional outcomes in female neobladder patients
2013
A Randomized Trial of Radical Radiotherapy for the Management of pT1G3 NXM0 Transitional Cell Carcinoma of the Bladder
2007
The CXC chemokine SDF-1 is the ligand for LESTR/fusin and prevents infection by T-cell-line-adapted HIV-1
1996 StandoutNature
The mechanism of action of BCG therapy for bladder cancer—a current perspective
2014
Second cancer risk following testicular cancer: a follow-up study of 1,909 patients.
1993
Ureteral and Urethral Frozen Sections During Radical Cystectomy or Cystoprostatectomy: An Analysis of Denudation and Atypia
2014
Acute Renal Colic from Ureteral Calculus
2004
Ureteroscopic and percutaneous management of upper tract urothelial carcinoma (UTUC): systematic review
2012
Retinoids: present role and future potential
1999
Treatment Options Available for Bacillus Calmette-Guérin Failure in Non–muscle-invasive Bladder Cancer
2012
Risk Assessment of Prostatic Pathology in Patients Undergoing Radical Cystoprostatectomy
2007
HLA class I-restricted cytotoxic T lymphocytes specific for hepatitis C virus. Identification of multiple epitopes and characterization of patterns of cytokine release.
1995 StandoutNobel
Bacillus Calmette–Guérin treatment of non‐muscle invasive bladder cancer
2010
Comorbidity and Performance Indices as Predictors of Cancer-Independent Mortality But Not of Cancer-Specific Mortality After Radical Cystectomy for Urothelial Carcinoma of the Bladder
2012
Extended Versus Limited Lymph Node Dissection in Bladder Cancer Patients Undergoing Radical Cystectomy: Survival Results from a Prospective, Randomized Trial
2018
Preservation of the internal genital organs during radical cystectomy in selected women with bladder cancer: A report on 15 cases with long term follow-up
2013
A Single-centre Early Phase Randomised Controlled Three-arm Trial of Open, Robotic, and Laparoscopic Radical Cystectomy (CORAL)
2015
Survival benefit of adjuvant radiotherapy in stage III and IV bladder cancer: results of 170 patients
2014
TUR and Adjuvant Intravesical Chemotherapy in T1G3 Bladder Tumors: Recurrence, Progression and Survival in 137 Selected Patients Followed Up to 20 Years
2003
Systematic review and meta‐analysis of monotherapy compared with combined androgen blockade for patients with advanced prostate carcinoma
2002
Risk-adapted strategy for the kidney-sparing management of upper tract tumours
2015
Abiraterone plus Prednisone in Metastatic, Castration-Sensitive Prostate Cancer
2017 Standout
Safety and efficacy of long-acting somatostatin treatment in autosomal-dominant polycystic kidney disease
2005
CD40 ligand on activated platelets triggers an inflammatory reaction of endothelial cells
1998 StandoutNature
Novel aspects of inflammation: interleukin-8 and related chemotactic cytokines
1993
Follow-up After Surgical Treatment of Bladder Cancer: A Critical Analysis of the Literature
2012
Oncological and functional outcomes of sexual function–preserving cystectomy compared with standard radical cystectomy in men: A systematic review
2017
Systematic Review and Cumulative Analysis of Oncologic and Functional Outcomes After Robot-assisted Radical Cystectomy
2015
Alvimopan Accelerates Gastrointestinal Recovery After Radical Cystectomy: A Multicenter Randomized Placebo-Controlled Trial
2014
Interleukin-8 and related chemotactic cytokines--CXC and CC chemokines.
1994 Standout
Detection of Asymptomatic Recurrence During Routine Oncological Followup After Radical Cystectomy is Associated With Improved Patient Survival
2011
FUNCTIONAL RESULTS OF ORTHOTOPIC ILEAL NEOBLADDER WITH SEROUS-LINED EXTRAMURAL URETERAL REIMPLANTATION: EXPERIENCE WITH 450 PATIENTS
2001
Upper Urinary Tract Carcinoma In Situ: Current Knowledge, Future Direction
2016
Definitions, End Points, and Clinical Trial Designs for Non–Muscle-Invasive Bladder Cancer: Recommendations From the International Bladder Cancer Group
2016
Phase II Study of Conformal Hypofractionated Radiotherapy With Concurrent Gemcitabine in Muscle-Invasive Bladder Cancer
2011
Coordinating Radiometals of Copper, Gallium, Indium, Yttrium, and Zirconium for PET and SPECT Imaging of Disease
2010 Standout
HEALTH RELATED QUALITY OF LIFE AFTER RADICAL CYSTECTOMY AND URINARY DIVERSION FOR BLADDER CANCER: A SYSTEMATIC REVIEW AND CRITICAL ANALYSIS OF THE LITERATURE
2005
Comparative impact of continent and incontinent urinary diversion on long‐term renal function after radical cystectomy in patients with preoperative chronic kidney disease 2 and chronic kidney disease 3a
2015
Results with radical cystectomy for treating bladder cancer: a ‘reference standard’ for high‐grade, invasive bladder cancer
2003
Radical cystectomy with orthotopic neobladder for invasive bladder cancer: a critical analysis of long term oncological, functional and quality of life results
2010
Sarcopenia as a comorbidity‐independent predictor of survival following radical cystectomy for bladder cancer
2018
Renal sympathetic denervation in patients with treatment-resistant hypertension (The Symplicity HTN-2 Trial): a randomised controlled trial
2010 Standout
The Role of Perioperative Chemotherapy in the Treatment of Urothelial Cancer
2006
Neoadjuvant Chemotherapy in Invasive Bladder Cancer: Update of a Systematic Review and Meta-Analysis of Individual Patient Data
2005 Standout
Extended vs non‐extended pelvic lymph node dissection and their influence on recurrence‐free survival in patients undergoing radical cystectomy for bladder cancer: a systematic review and meta‐analysis of comparative studies
2013
Cardiovascular Mortality After Androgen Deprivation Therapy for Locally Advanced Prostate Cancer: RTOG 85-31
2008
A Phase II Clinical Trial of Neoadjuvant Ketoconazole and Docetaxel Chemotherapy Before Radical Prostatectomy in High Risk Patients
2011
Growth factor involvement in progression of prostate cancer.
1998
Prospective Evaluation of Continence Following Radical Cystectomy and Orthotopic Urinary Diversion Using a Validated Questionnaire
2016
Nanotechnology for Multimodal Synergistic Cancer Therapy
2017 Standout
Follow-up after radical cystectomy based on patterns of tumor recurrence and its risk factors
2013
Intravesical instillation of bacille Calmette-Guérin for carcinoma in situ of the urothelium involving the upper urinary tract using vesicoureteral reflux created by a double-pigtail catheter
2002
THE ORTHOTOPIC T POUCH ILEAL NEOBLADDER: EXPERIENCE WITH 209 PATIENTS
2004
CARCINOMA-IN-SITU TESTIS IN PATIENTS WITH ASSUMED EXTRAGONADAL GERM-CELL TUMOURS
1987
Maximizing survival in patients with muscle-invasive bladder cancer undergoing curative bladder-preserving radiotherapy: the impact of radiotherapy dose escalation
2017
Tissue-engineered autologous bladders for patients needing cystoplasty
2006 Standout
PROGNOSTIC FACTORS OF OUTCOME AFTER RADICAL CYSTECTOMY FOR BLADDER CANCER: A RETROSPECTIVE STUDY OF A HOMOGENEOUS PATIENT COHORT
1999
Initial Hormonal Management of Androgen-Sensitive Metastatic, Recurrent, or Progressive Prostate Cancer: 2007 Update of an American Society of Clinical Oncology Practice Guideline
2007
MAINTENANCE BACILLUS CALMETTE-GUERIN IMMUNOTHERAPY FOR RECURRENT TA, T1 AND CARCINOMA IN SITU TRANSITIONAL CELL CARCINOMA OF THE BLADDER: A RANDOMIZED SOUTHWEST ONCOLOGY GROUP STUDY
2000 Standout
Comparative Analysis of Transperineal Template Saturation Prostate Biopsy Versus Magnetic Resonance Imaging Targeted Biopsy with Magnetic Resonance Imaging-Ultrasound Fusion Guidance
2014
The Effectiveness of Off-Protocol Adjuvant Chemotherapy for Patients with Urothelial Carcinoma of the Urinary Bladder
2010
Outcomes of Radical Cystectomy for Transitional Cell Carcinoma of the Bladder: A Contemporary Series From the Bladder Cancer Research Consortium
2006
Initial Tumor Stage and Grade as a Predictive Factor for Recurrence in Patients With Stage T1 Grade 3 Bladder Cancer
2004
Preoperative serum albumin is associated with mortality and complications after radical cystectomy
2013
PROSPECTIVELY PACKAGED LYMPH NODE DISSECTIONS WITH RADICAL CYSTECTOMY: EVALUATION OF NODE COUNT VARIABILITY AND NODE MAPPING
2004
Prostatic Urethral Biopsy Has Limited Usefulness in Counseling Patients Regarding Final Urethral Margin Status During Orthotopic Neobladder Reconstruction
2008
Optimizing bladder cancer locoregional failure risk stratification after radical cystectomy using SWOG 8710
2014
Upper Urinary Tract Recurrence Following Radical Cystectomy for Bladder Cancer: A Meta-Analysis on 13,185 Patients
2012
Intravesical Bacillus Calmette-Guerin Versus Mitomycin C For Superficial Bladder Cancer: A Formal Meta-Analysis of Comparative Studies on Recurrence and Toxicity
2003
A New Concept for Early Recovery after Surgery for Patients Undergoing Radical Cystectomy for Bladder Cancer: Results of a Prospective Randomized Study
2013
Complications of the Afferent Antireflux Valve Mechanism in the Kock Ileal Reservoir
1996
Hidden in Plain Sight — Reconsidering the Use of Race Correction in Clinical Algorithms
2020 Standout
Utility and significance of ureteric frozen section analysis during radical cystectomy
2015
Radiochemotherapy After Transurethral Resection for High-Risk T1 Bladder Cancer: An Alternative to Intravesical Therapy or Early Cystectomy?
2006
Risk of Fracture After Radical Cystectomy and Urinary Diversion for Bladder Cancer
2014
Prospective comparison of quality‐of‐life outcomes between ileal conduit urinary diversion and orthotopic neobladder reconstruction after radical cystectomy: a statistical model
2013
Robot‐assisted radical cystectomy
2015
Adjuvant Chemotherapy in Invasive Bladder Cancer: A Systematic Review and Meta-Analysis of Individual Patient Data
2005
Reactive Oxygen Species (ROS)-Based Nanomedicine
2019 Standout
ASSESSMENT OF VESICOURETERAL REFLUX IN PATIENTS WITH SELF-RETAINING URETERAL STENTS: IMPLICATIONS FOR UPPER URINARY TRACT INSTILLATION
2005
Imaging and Photodynamic Therapy: Mechanisms, Monitoring, and Optimization
2010 Standout
p53 Immunohistochemistry as a Prognostic Marker in Bladder Cancer
2000
QUALITY OF LIFE OUTCOMES AFTER BRACHYTHERAPY FOR EARLY STAGE PROSTATE CANCER
2000
Segmental Ureterectomy Can Safely be Performed in Patients With Transitional Cell Carcinoma of the Ureter
2010
Systematic review of the oncological and functional outcomes of pelvic organ‐preserving radical cystectomy ( RC ) compared with standard RC in women who undergo curative surgery and orthotopic neobladder substitution for bladder cancer
2017
15-year survival rates after transurethral resection and radiochemotherapy or radiation in bladder cancer treatment.
2011
Magnetic Nanoparticles: Design and Characterization, Toxicity and Biocompatibility, Pharmaceutical and Biomedical Applications
2012 Standout
Urinary Functional Outcome Following Radical Cystoprostatectomy and Ileal Neobladder Reconstruction in Male Patients
2012
A Surveillance Study of Clinical Stage I Nonseminomatous Germ Cell Tumors of the Testis: 10-Year Followup
1995
Concurrent chemotherapy is associated with improved survival in elderly patients with bladder cancer undergoing radiotherapy
2017
Urothelial Carcinoma of the Bladder and the Upper Tract: Disparate Twins
2012
Development of individualized anti-metastasis strategies by engineering nanomedicines
2015
Potential toxicity of superparamagnetic iron oxide nanoparticles (SPION)
2010
THE 3-MONTH CLINICAL RESPONSE TO INTRAVESICAL THERAPY AS A PREDICTIVE FACTOR FOR PROGRESSION IN PATIENTS WITH HIGH RISK SUPERFICIAL BLADDER CANCER
2000
Is There a Therapeutic Role for Post-Chemotherapy Retroperitoneal Lymph Node Dissection in Metastatic Transitional Cell Carcinoma of the Bladder?
2003
Postoperative Pain Management after Radical Cystectomy: Comparing Traditional versus Enhanced Recovery Protocol Pathway
2015
Effectiveness of Adjuvant Chemotherapy for Locally Advanced Bladder Cancer
2016
Peptide Receptors as Molecular Targets for Cancer Diagnosis and Therapy
2003
METABOLIC CONSEQUENCES AND LONG-TERM COMPLICATIONS OF ENTEROCYSTOPLASTY IN CHILDREN: A REVIEW
2005
Works of Urs E. Studer being referenced
Immediate or Deferred Androgen Deprivation for Patients With Prostate Cancer Not Suitable for Local Treatment With Curative Intent: European Organisation for Research and Treatment of Cancer (EORTC) Trial 30891
2006
Readaptation of the Peritoneum Following Extended Pelvic Lymphadenectomy and Cystectomy Has a Significant Beneficial Impact on Early Postoperative Recovery and Complications: Results of a Prospective Randomized Trial
2010
Continent urinary diversion
2005
Arguments against the Long-Term Use of Combined Androgen Blockade
1998
Diabetes Mellitus: Does It Impair Urinary Continence after Radical Cystoprostatectomy and Ileal Orthotopic Bladder Substitution?
2007
Contemporary cystectomy and urinary diversion
2002
Small‐cell undifferentiated carcinoma of the renal pelvis 26 years after subdiaphragmatic irradiation for non‐Hodgkin's lymphoma
1995
Increased proximal urethral sensory threshold after radical pelvic surgery in women
2006
ENDOPYELOTOMY FOR PRIMARY URETEROPELVIC JUNCTION OBSTRUCTION: RISK FACTORS DETERMINE THE SUCCESS RATE
1998
Elective management of transitional cell carcinoma of the distal ureter: can kidney‐sparing surgery be advised?
2007
Bladder Substitution with an Ileal Low-Pressure Reservoir
1988
Bacillus Calmette-Guérin Failure in Patients with Non–Muscle-invasive Urothelial Carcinoma of the Bladder May Be Due to the Urologist's Failure to Detect Urothelial Carcinoma of the Upper Urinary Tract and Urethra
2013
Long-term results of standard procedures in urology: the ileal neobladder
2006
Tumor Seeding Following Percutaneous Antegrade Treatment of Transitional Cell Carcinoma in the Renal Pelvis
2004
Urinary Diversion: How Experts Divert
2014
Induction chemotherapy for unresectable urothelial carcinoma of the bladder
2010
Adjuvant Chemotherapy afterOrchiectomy in High-Risk Patientswith Clinical Stage INon-SeminomatousTesticular Cancer
1993
Antegrade Perfusion With Bacillus Calmette-Guérin in Patients With Non–Muscle-Invasive Urothelial Carcinoma of the Upper Urinary Tract: Who May Benefit?
2011
Do Patients Benefit from Routine Follow-up to Detect Recurrences After Radical Cystectomy and Ileal Orthotopic Bladder Substitution?
2010
Adjuvant Treatment with aVitamin A Analogue (Etretinate)after Transurethral Resection ofSuperficial Bladder Tumors
1995
Using PSA to Guide Timing of Androgen Deprivation in Patients with T0–4 N0–2 M0 Prostate Cancer not Suitable for Local Curative Treatment (EORTC 30891)
2007
No Evidence of Osteopenia 5 to 8 Years After Ileal Orthotopic Bladder Substitution
1996
Combined Ultrasmall Superparamagnetic Particles of Iron Oxide–Enhanced and Diffusion-weighted Magnetic Resonance Imaging Facilitates Detection of Metastases in Normal-sized Pelvic Lymph Nodes of Patients with Bladder and Prostate Cancer
2013
Metastases in Normal-sized Pelvic Lymph Nodes: Detection with Diffusion-weighted MR Imaging
2014
A New Multimodality Technique Accurately Maps the Primary Lymphatic Landing Sites of the Bladder
2009
Long-term Renal Function After Urinary Diversion by Ileal Conduit or Orthotopic Ileal Bladder Substitution
2011
Botulinum A toxin injections into the detrusor: An effective treatment in idiopathic and neurogenic detrusor overactivity?
2005
Orthotopic Ileal Bladder Substitution in Women: Factors Influencing Urinary Incontinence and Hypercontinence
2015
Differential expression of transforming growth factor-?1 and ?3 as well as C-FOS mRNA in normal human prostate, benign prostatic hyperplasia and prostatic cancer
1994
The role of lymphadenectomy in high risk prostate cancer
2008
Three Years' Experience with an Ileal Low Pressure Bladder Substitute
1989
Analysis of early failures after intravesical instillation therapy with bacille Calmette‐Guerin for carcinoma in situ of the bladder
1995
Parenteral Nutrition Does Not Improve Postoperative Recovery from Radical Cystectomy: Results of a Prospective Randomised Trial
2012
Orchidectomy versus buserelin in combination with cyproterone acetate, for 2 weeks or continuously, in the treatment of metastatic prostatic cancer. Preliminary results of EORTC-trial 30843
1990
Orthotopic ileal neobladder
2003
Complications Following Radical Cystectomy for Bladder Cancer in the Elderly
2009
ILEAL ORTHOTOPIC BLADDER SUBSTITUTES
1997
Nerve-Sparing Radical Cystectomy and Orthotopic Bladder Replacement in Female Patients
2007
Pelvic Lymph Node Dissection in Prostate Cancer
2009
Clinical Indications and Outcomes with Nerve-sparing Cystectomy in Patients with Bladder Cancer
2005
Combined Ultrasmall Superparamagnetic Particles of Iron Oxide–Enhanced and Diffusion-Weighted Magnetic Resonance Imaging Reliably Detect Pelvic Lymph Node Metastases in Normal-Sized Nodes of Bladder and Prostate Cancer Patients
2009
ICUD-EAU International Consultation on Bladder Cancer 2012: Urinary Diversion
2012
Immunohistochemical determination of p53 overexpression
1997
Summary of 10 years' experience with an ileal low-pressure bladder substitute combined with an afferent tubular isoperistaltic segment
1996
Outcome of Patients withUntreated Cancer of theProstate
1993
Lymphadenectomy for Bladder Cancer: Indications and Controversies
2011
The Impact of Lymphadenectomy and Lymph Node Metastasis on the Outcomes of Radical Cystectomy for Bladder Cancer
2009
Managing patients after an ileal orthotopic bladder substitution
2004
THE EFFECT OF NERVE SPARING CYSTECTOMY TECHNIQUE ON POSTOPERATIVE CONTINENCE AFTER ORTHOTOPIC BLADDER SUBSTITUTION
1997
Prevalence of Nephrolithiasis in Patients with Ileal Bladder Substitutes
2008
Why phase III trials of maximal androgen blockade versus castration in M1 prostate cancer rarely show statistically significant differences*
2001
INTERLEUKIN-8 EXPRESSION IN THE URINE AFTER BACILLUS CALMETTE-GUERIN THERAPY: A POTENTIAL PROGNOSTIC FACTOR OF TUMOR RECURRENCE AND PROGRESSION
1997
ATTEMPTED NERVE SPARING SURGERY AND AGE HAVE A SIGNIFICANT EFFECT ON URINARY CONTINENCE AND ERECTILE FUNCTION AFTER RADICAL CYSTOPROSTATECTOMY AND ILEAL ORTHOTOPIC BLADDER SUBSTITUTION
2004
Percutaneous Bacillus Calmette-Guerin Perfusion of the Upper Urinary Tract for Carcinoma in Situ
1989
FEMALE ORTHOTOPIC BLADDER SUBSTITUTION: A GOOD OPERATION IN THE RIGHT CIRCUMSTANCES
2000
Intravesical Versus Intravesical Plus Intradermal Bacillus Calmette-Guerin: A Prospective Randomized Study In Patient With Recurrent Superficial Bladder Tumors
1996
Extracapsular Extension of Pelvic Lymph Node Metastases From Urothelial Carcinoma of the Bladder Is an Independent Prognostic Factor
2005
Alternate or Additional Findings to Stone Disease on Unenhanced Computerized Tomography for Acute Flank Pain Can Impact Management
2006
Is a Limited Lymph Node Dissection An Adequate Staging Procedure for Prostate Cancer?
2002
Urinary Diversion
2007
Neutrophil-Activating Peptide-1/Interleukin-8 Detection in Human Urine during Acute Bladder Inflammation Caused by Transurethral Resection of Superficial Cancer and Bacillus Calmette-Guérin Administration
1991
The Efficiency of Excretory Urography to Detect Upper Urinary Tract Tumors After Cystectomy for Urothelial Cancer
2007
PRIMARY T1G3 BLADDER CANCER: ORGAN PRESERVING APPROACH OR IMMEDIATE CYSTECTOMY?
2004
Extracorporeal Shock Wave Lithotripsy in Situ or after Push-Up for Upper Ureteral Calculi: A Prospective Randomized Trial
1993
Outcome After Radical Cystectomy With Limited or Extended Pelvic Lymph Node Dissection
2008
How to Obtain Good Results with Orthotopic Bladder Substitution: The 10 Commandments
2009
Bladder Replacement and Urinary Diversion
2000
Long-Term Voiding Pattern of Patients With Ileal Orthotopic Bladder Substitutes
2002
TREATMENT OF URETHRAL RECURRENCE FOLLOWING RADICAL CYSTECTOMY AND ILEAL BLADDER SUBSTITUTION
2004
Long-term Experience With Bacillus Calmette-Guerin Therapy of Upper Urinary Tract Transitional Cell Carcinoma in Patients Not Eligible for Surgery
2002
Is Eligibility for a Chemotherapy Protocol a Good Prognostic Factor for Invasive Bladder Cancer After Radical Cystectomy?
2004
A retrospective analysis of 153 patients treated with or without intravesical bacillus Calmette-Guerin for primary stage T1 grade 3 bladder cancer: recurrence, progression and survival.
2003
To Stent or Not to Stent Perioperatively the Ureteroileal Anastomosis of Ileal Orthotopic Bladder Substitutes and Ileal Conduits? Results of a Prospective Randomized Trial
2007
PELVIC LYMPH NODE METASTASES FROM BLADDER CANCER: OUTCOME IN 83 PATIENTS AFTER RADICAL CYSTECTOMY AND PELVIC LYMPHADENECTOMY
2001
SYSTEMIC AND TOPICAL DRUG ADMINISTRATION IN THE PIG URETER: EFFECT OF PHOSPHODIESTERASE INHIBITORS α1, β AND β2-ADRENERGIC RECEPTOR AGONISTS AND ANTAGONISTS ON THE FREQUENCY AND AMPLITUDE OF URETERAL CONTRACTIONS
2001
Outcomes of radical cystectomy with extended lymphadenectomy alone in patients with lymph node‐positive bladder cancer who are unfit for or who decline adjuvant chemotherapy
2013
Is Bilateral Extended Pelvic Lymphadenectomy Necessary for Strictly Unilateral Invasive Bladder Cancer?
2012
Long-Term Outcome of Ileal Conduit Diversion.
2003
A Retrospective Analysis of 153 Patients Treated With or Without Intravesical Bacillus Calmette-Guerin for Primary Stage T1 Grade 3 Bladder Cancer: Recurrence, Progression and Survival
2003
Bladder reconstruction with bowel after radical cystectomy
1992
Bilateral Testicular Germ Cell Tumors: A Report of 20 Cases
1987
URINARY INTERLEUKIN-8 AND 18 PREDICT THE RESPONSE OF SUPERFICIAL BLADDER CANCER TO INTRAVESICAL THERAPY WITH BACILLUS CALMETTE-GUERIN
2000
Noninvasive Anesthesia, Analgesia And Radiation-Free Extracorporeal Shock Wave Lithotripsy For Stones In The Most Distal Ureter: Experience With 165 Patients
2002
A Prospective Randomized Trial Comparing 2 Lithotriptors for Stone Disintegration and Induced Renal Trauma
2003
Radical Cystectomy for Bladder Cancer Today—A Homogeneous Series Without Neoadjuvant Therapy
2003 Standout
Immediate Versus Deferred Hormonal Treatment for Patients With Prostate Cancer Who Are Not Suitable for Curative Local Treatment: Results of the Randomized Trial SAKK 08/88
2004
DuCaP AND VCaP ARE ANDROGEN-DEPENDENT PROSTATE CANCER CELL LINES THAT FORM OSTEOBLASTIC BONE METASTASES
2008
Adjuvant Cisplatin Chemotherapy Following Cystectomy for Bladder Cancer: Results of a Prospective Randomized Trial
1994
PELVIC LYMPH NODE METASTASES FROM BLADDER CANCER: OUTCOME IN 83 PATIENTS AFTER RADICAL CYSTECTOMY AND PELVIC LYMPHADENECTOMY
2001
Human kidney as target for somatostatin: high affinity receptors in tubules and vasa recta.
1993
Long-term Experience With Bacillus Calmette-Guerin Therapy of Upper Urinary Tract Transitional Cell Carcinoma in Patients Not Eligible for Surgery
2002
Primary or Secondary Extragonadal Germ Cell Tumors?
1986
A newer form of bladder substitute based on historical perspectives.
1988
Experience in 100 Patients with an Ileal Low Pressure Bladder Substitute Combined with an Afferent Tubular Isoperistaltic Segment
1995
Super Extended Versus Extended Pelvic Lymph Node Dissection in Patients Undergoing Radical Cystectomy for Bladder Cancer: A Comparative Study
2011
Early and Late Urodynamic Assessment of Ileal Orthotopic Bladder Substitutes Combined With an Afferent Tubular Segment
2006
Manejo perioperatorio y resultados en pacientes con neovejiga ileal ortotópica
2008
Is There an Indication for Frozen Section Examination of the Ureteral Margins During Cystectomy for Transitional Cell Carcinoma of the Bladder?
2006
No Evidence of Osteopenia 5 to 8 Years After Ileal Orthotopic Bladder Substitution
1996
Antireflux Nipples or Afferent Tubular Segments in 70 Patients with Ileal Low Pressure Bladder Substitutes: Long-term Results of a Prospective Randomized Trial
1996
Diffusion-Weighted Magnetic Resonance Imaging Detects Significant Prostate Cancer with High Probability
2014
Enlargement of Regional Lymph Nodes in Renal Cell Carcinoma is Often not Due to Metastases
1990
Twenty Years Experience With an Ileal Orthotopic Low Pressure Bladder Substitute—Lessons to be Learned
2006
Reconstruction of the urinary tract after radical cystectomy: The case for continent urinary diversion
1997
Disease Progression and Survival of Patients With Positive Lymph Nodes After Radical Prostatectomy. Is there a Chance of Cure?
2003
Is Ileal Orthotopic Bladder Substitution with an Afferent Tubular Segment Detrimental to the Upper Urinary Tract in the Long Term?
2002
METABOLIC CONSEQUENCES OF CONTINENT URINARY DIVERSION
1999
TISSUE MICROARRAY ANALYSIS OF hMSH2 EXPRESSION PREDICTS OUTCOME IN MEN WITH PROSTATE CANCER
2005